Enhanced Genomics, the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, has announced that Katerina ...
Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn’s disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 ...
Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:Raymond James 47th Annual Institutional Investors ConferenceMonday, March 2, 20267:30 a.m. ET - Max ...
16hon MSN
Penn is part of a $135.7M federal effort to demystify a blind spot in medicine: the lymphatic system
The University of Pennsylvania is getting $7.8 million over the next two years to study an overlooked aspect of human health: the lymphatic system. Often described as the body’s sewer system, its main ...
UL Research Institutes' Chemical Insights scientists working to better understand the human health impacts of chemicals will be recognized at the 2026 Society of Toxicology (SOT) Annual Meeting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results